Cargando…
Design, molecular docking, drug-likeness, and molecular dynamics studies of 1,2,4-trioxane derivatives as novel Plasmodium falciparum falcipain-2 (FP-2) inhibitors
Despite significant progress made in drug discovery and development over the past few decades, malaria remains a life-threatening infectious disease across the globe. Because of the widespread emergence of drug-resistant strains of Plasmodium falciparum, the clinical utility of existing drug therapi...
Autores principales: | Ghosh, Subham, Chetia, Dipak, Gogoi, Neelutpal, Rudrapal, Mithun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645569/ https://www.ncbi.nlm.nih.gov/pubmed/36606151 http://dx.doi.org/10.5114/bta.2021.108722 |
Ejemplares similares
-
Novel series of 1,2,4-trioxane derivatives as antimalarial agents
por: Rudrapal, Mithun, et al.
Publicado: (2017) -
Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold
por: Rudrapal, Mithun, et al.
Publicado: (2016) -
Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness/ADMET studies
por: Rudrapal, Mithun, et al.
Publicado: (2022) -
Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation
por: Gogoi, Bhaskarjyoti, et al.
Publicado: (2021) -
Hemoglobin Cleavage Site-Specificity of the Plasmodium falciparum Cysteine Proteases Falcipain-2 and Falcipain-3
por: Subramanian, Shoba, et al.
Publicado: (2009)